Patent details

EP2918288 Title: Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia

Basic Information

Publication number:
EP2918288
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151543931
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
French Title of Invention:
Utilisation d'antagonistes de TGF-BETA pour traiter des nourrissons risquant de développer une dysplasie broncho-pulmonaire
German Title of Invention:
Verwendung von TGF-beta-Antagonisten zur Behandlung von Kleinkindern mit dem Risiko der Entwicklung von bronchopulmonaler Dysplasie
SPC Number:

Dates

Filing date:
03/10/2007
Grant date:
16/08/2017
EP Publication Date:
16/09/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/08/2017
EP B1 Publication Date:
16/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/10/2017
Expiration date:
03/10/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/06/2018
 
 

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Name:
The General Hospital Corporation
Address:
Massachusetts General Hospital 55 Fruit Street, Boston, MA 02114, United States (US)

History of Owners

From:
16/08/2017
To:
15/06/2018

Name:
Genzyme Corporation
Address:
500 Kendall Street, Cambridge, MA 02142, United States (US)

Name:
The General Hospital Corporation
Address:
Massachusetts General Hospital 55 Fruit Street, Boston, MA 02114, United States (US)

Inventor

1

Name:
Streisand, James B.
Address:
United States (US)

2

Name:
Roberts, Jesse D.
Address:
United States (US)

Priority

Priority Number:
827933 P
Priority Date:
03/10/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 39/395; A61K 45/06; A61P 11/00; C07K 16/22;

Publication

European Patent Bulletin

1

Issue number:
201733
Publication date:
16/08/2017
Description:
Grant (B1)

2

Issue number:
201734
Publication date:
23/08/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201829
Publication date:
18/07/2018
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2018 Outgoing Correspondence 1